Work

Additional file 2 of BAFF is a marker of hypogammaglobulinemia, neuroaxonal damage and inflammation in multiple sclerosis patients on ocrelizumab

Year: 2026

Type: article

Abstract: Supplementary Material 2: Supplementary Fig. 2. Correlations between BAFF, other clinical variables and serum biomarkers in patients on ocrelizumab. P-values adjusted for false discovery rate are shown and green indicates statistically significant correlations.

Source: Figshare

DOI: 10.6084/m9.figshare.30994824

Authors: Chumakova, Anastasia, McKay, Lauren, Fleming, Victoria, Demetriou, Michael, Sy, Michael

Institution: University of California, Irvine

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7118187301

FWCI:

Cites:

Cited by:

Related to: 10